This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Angelakopoulos, H.
Right arrow Articles by Hohmann, E. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Angelakopoulos, H.
Right arrow Articles by Hohmann, E. L.

 Previous Article  |  Next Article 

Infection and Immunity, July 2002, p. 3592-3601, Vol. 70, No. 7
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.7.3592-3601.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Safety and Shedding of an Attenuated Strain of Listeria monocytogenes with a Deletion of actA/plcB in Adult Volunteers: a Dose Escalation Study of Oral Inoculation

Haroula Angelakopoulos,1 Katharina Loock,1 David M. Sisul,1 Eric R. Jensen,2 Jeff F. Miller,2 and Elizabeth L. Hohmann1*

Infectious Diseases Division, Massachusetts General Hospital, Boston, Massachussetts 02114,1 Department of Microbiology and Immunology, University of California at Los Angeles School of Medicine, Los Angeles, California 942702

Received 19 February 2002/ Returned for modification 28 March 2002/ Accepted 17 April 2002

Listeria monocytogenes is an intracellular bacterial pathogen which causes bacteremia and has a tropism for the central nervous system and a propensity to cause maternofetal infection. L. monocytogenes has been shown to be an effective prophylactic and a therapeutic vaccine vector for viral and tumor antigens in animal models. L. monocytogenes mutants lacking the ActA protein, which is essential for intracellular movement, are attenuated but retain immunogenicity in mice. Given the pathogenic potential of L. monocytogenes, we created an attenuated mutant strain bearing double deletions in the actA and plcB virulence genes for an initial clinical safety study of a prototype L. monocytogenes vector in adults. Twenty healthy volunteers received single escalating oral doses (106 to 109 CFU, 4 volunteers per dose cohort) of this attenuated L. monocytogenes, designated LH1169. Volunteers were monitored in the hospital for 14 days with frequent clinical checks and daily blood and stool cultures, and they were monitored for six additional weeks as outpatients. There were no positive blood cultures and no fevers attributable to the investigational inoculation. Most volunteers shed vaccine bacteria for 4 days or less, without diarrhea. One volunteer had a late positive stool culture during outpatient follow-up. Three volunteers had abnormal liver function test results temporally associated with inoculation; one could be reasonably attributed to another cause. In the highest-dose cohort, humoral, mucosal, and cellular immune responses to the investigational organism were detected in individual volunteers. Attenuated L. monocytogenes can be studied in adult volunteers without serious long-term health sequelae.

* Corresponding author. Mailing address: Infectious Diseases Division, Gray/Jackson 504, Massachusetts General Hospital, 55 Fruit St., Boston, MA 02114. Phone: (617) 724-7532. Fax: (617) 724-3761. E-mail: ehohmann{at}partners.org.

Editor: D. L. Burns

Infection and Immunity, July 2002, p. 3592-3601, Vol. 70, No. 7
0019-9567/02/$04.00+0     DOI: 10.1128/IAI.70.7.3592-3601.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Richter, J. F., Gitter, A. H., Gunzel, D., Weiss, S., Mohamed, W., Chakraborty, T., Fromm, M., Schulzke, J. D. (2009). Listeriolysin O affects barrier function and induces chloride secretion in HT-29/B6 colon epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G1350-G1359 [Abstract] [Full Text]  
  • Lenz, L. L., Huang, W. A., Zhou, C., Li, Z., Calendar, R. (2008). Stable Integration Vector for Nutrient Broth-Based Selection of Attenuated Listeria monocytogenes Strains with Recombinant Antigen Expression. CVI 15: 1414-1419 [Abstract] [Full Text]  
  • Wegmann, K. W., Wagner, C. R., Whitham, R. H., Hinrichs, D. J. (2008). Synthetic Peptide Dendrimers Block the Development and Expression of Experimental Allergic Encephalomyelitis. J. Immunol. 181: 3301-3309 [Abstract] [Full Text]  
  • Yan, L., Qiu, J., Chen, J., Ryan-Payseur, B., Huang, D., Wang, Y., Rong, L., Melton-Witt, J. A., Freitag, N. E., Chen, Z. W. (2008). Selected prfA* Mutations in Recombinant Attenuated Listeria monocytogenes Strains Augment Expression of Foreign Immunogens and Enhance Vaccine-Elicited Humoral and Cellular Immune Responses. Infect. Immun. 76: 3439-3450 [Abstract] [Full Text]  
  • Lauer, P., Hanson, B., Lemmens, E. E., Liu, W., Luckett, W. S., Leong, M. L., Allen, H. E., Skoble, J., Bahjat, K. S., Freitag, N. E., Brockstedt, D. G., Dubensky, T. W. Jr. (2008). Constitutive Activation of the PrfA Regulon Enhances the Potency of Vaccines Based on Live-Attenuated and Killed but Metabolically Active Listeria monocytogenes Strains. Infect. Immun. 76: 3742-3753 [Abstract] [Full Text]  
  • Kimman, T. G., Smit, E., Klein, M. R. (2008). Evidence-Based Biosafety: a Review of the Principles and Effectiveness of Microbiological Containment Measures. Clin. Microbiol. Rev. 21: 403-425 [Abstract] [Full Text]  
  • Li, Z., Zhao, X., Zhou, C., Gu, B., Frankel, F. R. (2006). A truncated Bacillus subtilis dal gene with a 3' ssrA gene tag regulates the growth and virulence of racemase-deficient Listeria monocytogenes.. Microbiology 152: 3091-3102 [Abstract] [Full Text]  
  • Loeffler, D. I. M., Schoen, C. U., Goebel, W., Pilgrim, S. (2006). Comparison of Different Live Vaccine Strategies In Vivo for Delivery of Protein Antigen or Antigen-Encoding DNA and mRNA by Virulence-Attenuated Listeria monocytogenes. Infect. Immun. 74: 3946-3957 [Abstract] [Full Text]  
  • Bouwer, H. G. A., Alberti-Segui, C., Montfort, M. J., Berkowitz, N. D., Higgins, D. E. (2006). Directed antigen delivery as a vaccine strategy for an intracellular bacterial pathogen. Proc. Natl. Acad. Sci. USA 103: 5102-5107 [Abstract] [Full Text]  
  • Hardy, J., Margolis, J. J., Contag, C. H. (2006). Induced Biliary Excretion of Listeria monocytogenes. Infect. Immun. 74: 1819-1827 [Abstract] [Full Text]  
  • Roback, J. D. (2006). Vaccine-Enhanced Donor Lymphocyte Infusion (veDLI). ASH Education Book 2006: 486-491 [Abstract] [Full Text]  
  • Zhao, X., Li, Z., Gu, B., Frankel, F. R. (2005). Pathogenicity and Immunogenicity of a Vaccine Strain of Listeria monocytogenes That Relies on a Suicide Plasmid To Supply an Essential Gene Product. Infect. Immun. 73: 5789-5798 [Abstract] [Full Text]  
  • Li, Z., Zhao, X., Higgins, D. E., Frankel, F. R. (2005). Conditional Lethality Yields a New Vaccine Strain of Listeria monocytogenes for the Induction of Cell-Mediated Immunity. Infect. Immun. 73: 5065-5073 [Abstract] [Full Text]  
  • Kotton, C. N., Hohmann, E. L. (2004). Enteric Pathogens as Vaccine Vectors for Foreign Antigen Delivery. Infect. Immun. 72: 5535-5547 [Full Text]  
  • Stritzker, J., Janda, J., Schoen, C., Taupp, M., Pilgrim, S., Gentschev, I., Schreier, P., Geginat, G., Goebel, W. (2004). Growth, Virulence, and Immunogenicity of Listeria monocytogenes aro Mutants. Infect. Immun. 72: 5622-5629 [Abstract] [Full Text]  
  • Stevens, R., Howard, K. E., Nordone, S., Burkhard, M., Dean, G. A. (2004). Oral Immunization with Recombinant Listeria monocytogenes Controls Virus Load after Vaginal Challenge with Feline Immunodeficiency Virus. J. Virol. 78: 8210-8218 [Abstract] [Full Text]  
  • Starks, H., Bruhn, K. W., Shen, H., Barry, R. A., Dubensky, T. W., Brockstedt, D., Hinrichs, D. J., Higgins, D. E., Miller, J. F., Giedlin, M., Bouwer, H. G. A. (2004). Listeria monocytogenes as a Vaccine Vector: Virulence Attenuation or Existing Antivector Immunity Does Not Diminish Therapeutic Efficacy. J. Immunol. 173: 420-427 [Abstract] [Full Text]  
  • Sewell, D. A., Douven, D., Pan, Z.-K., Rodriguez, A., Paterson, Y. (2004). Regression of HPV-Positive Tumors Treated With a New Listeria monocytogenes Vaccine. Arch Otolaryngol Head Neck Surg 130: 92-97 [Abstract] [Full Text]  
  • Roche, S. M., Gracieux, P., Albert, I., Gouali, M., Jacquet, C., Martin, P. M. V., Velge, P. (2003). Experimental Validation of Low Virulence in Field Strains of Listeria monocytogenes. Infect. Immun. 71: 3429-3436 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»